Comparative Pharmacology
Head-to-head clinical analysis: LIPOSYN III 10 versus NUTRILIPID 20.
Head-to-head clinical analysis: LIPOSYN III 10 versus NUTRILIPID 20.
LIPOSYN III 10% vs NUTRILIPID 20%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Liposyn III 10% is an intravenous fat emulsion that provides essential fatty acids (linoleic and linolenic acids) and a source of calories. The triglycerides are hydrolyzed by lipoprotein lipase to free fatty acids and glycerol, which are then utilized for energy production or stored. The emulsion particles are metabolized similarly to endogenous chylomicrons.
Nutrilipid 20% is an intravenous fat emulsion providing a source of calories and essential fatty acids. It is composed of soybean oil, egg yolk phospholipids, and glycerin. The triglycerides in the emulsion are hydrolyzed by lipoprotein lipase into free fatty acids and glycerol, which are then metabolized for energy production and incorporation into cell membranes.
Intravenous infusion: 500 mL to 1000 mL per day, providing 10% lipid emulsion (100 g fat per liter), infused over 8-12 hours as part of parenteral nutrition, not to exceed 2.5 g fat/kg/day.
Intravenous infusion of 20% lipid emulsion: 1-2 g/kg/day (5-10 mL/kg/day) as part of parenteral nutrition; maximum infusion rate: 0.11 g/kg/h (0.55 mL/kg/h).
None Documented
None Documented
Triglycerides in Liposyn III 10% have a terminal elimination half-life of approximately 0.5 to 1 hour in patients with normal lipid metabolism. In neonates or hepatic impairment, half-life may be prolonged.
The terminal elimination half-life of triglycerides in NUTRILIPID 20% is approximately 30 minutes in healthy adults with normal lipid metabolism. In critically ill or lipemic patients, clearance is delayed, and half-life can exceed 6 hours, necessitating monitoring of serum triglycerides.
Lipids are metabolized via hydrolysis by lipoprotein lipase into free fatty acids and glycerol. Free fatty acids undergo beta-oxidation or re-esterification. Elimination of CO2 via lungs; less than 5% excreted renally as glycerol and other metabolites.
NUTRILIPID 20% is a lipid emulsion; triglycerides are cleared from plasma via hydrolysis by lipoprotein lipase into free fatty acids and glycerol, which are then metabolized. Renal excretion of intact triglycerides is negligible (<1%); elimination is primarily metabolic, with less than 5% excreted unchanged in urine or feces.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion